Aclaris Therapeutics ACRS Operating margin

Operating margin at other companies

IncyteINCY

30.6%+4.8pp

Upstream Bio, Inc.UPB

-5,382.6%+1,393pp

Avalo TherapeuticsAVTX

-15,536.1%-17,275pp

Shattuck Labs, Inc.STTK

-5,578.7%-15,316pp

AnaptysBio, Inc.ANAB

17.6%+9.6pp

Alumis Inc.ALMS

-5,364%—

FAQ

What is Aclaris Therapeutics's operating margin?

Aclaris Therapeutics (ACRS) reported operating margin of -1,050.2% in Q2 2026.

How has Aclaris Therapeutics's operating margin changed year-over-year?

Aclaris Therapeutics's operating margin decreased by 20.2% year-over-year, from -873.4% to -1,050.2%.

What is the long-term trend for Aclaris Therapeutics's operating margin?

Over 5 years (2020 to 2025), Aclaris Therapeutics's operating margin has grown at a 4.4% compound annual growth rate (CAGR), from -785.4% to -975.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.